Kezar Life Scien Rg
Kezar Life Sciences, a South San Francisco‑based clinical‑stage biotech, develops novel small‑molecule therapies for immune‑mediated diseases. Its lead candidate, KZR‑616 (zetomipzomib), is in Phase 2 trials for lupus and related myositis.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 55
- HQ: South San Francisco
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.